Literature DB >> 29170028

Identification of cytotoxic, glutathione-reactive moieties inducing accumulation of reactive oxygen species via glutathione depletion.

Julian Wilke1, Tatsuro Kawamura2, Nobumoto Watanabe3, Hiroyuki Osada4, Slava Ziegler5, Herbert Waldmann6.   

Abstract

Reactive oxygen species (ROS) play an essential role in the survival and progression of cancer. Moderate oxidative stress drives proliferation, whereas high levels of ROS induce cytotoxicity. Compared to cancer cells, healthy cells often exhibit lower levels of oxidative stress. Elevation of cellular ROS levels by small molecules could therefore induce cancer-specific cytotoxicity. We have employed high-throughput phenotypic screening to identify inducers of ROS accumulation. We found 4,5-dihalo-2-methylpyridazin-3-one (DHMP) and 2,3,4,5(6)-tetrachloro-6(5)-methylpyridine (TCMP) moieties to strongly deplete GSH, to cause ROS accumulation and to induce cell death. Small molecules containing these fragments will most likely share the same properties and should therefore be carefully considered in the development of bioactive molecules.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cytotoxicity; Glutathione depletion; Reactive oxygen species; Small molecules

Mesh:

Substances:

Year:  2017        PMID: 29170028     DOI: 10.1016/j.bmc.2017.11.009

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Correlation of Reactive Oxygen Species Levels with Resveratrol Sensitivities of Anaplastic Thyroid Cancer Cells.

Authors:  Xu Zheng; Bin Jia; Xiao-Ting Tian; Xue Song; Mo-Li Wu; Qing-You Kong; Hong Li; Jia Liu
Journal:  Oxid Med Cell Longev       Date:  2018-07-10       Impact factor: 6.543

2.  2-Sulfonylpyrimidines as Privileged Warheads for the Development of S. aureus Sortase A Inhibitors.

Authors:  Fabian Barthels; Jessica Meyr; Stefan J Hammerschmidt; Tessa Marciniak; Hans-Joachim Räder; Wilma Ziebuhr; Bernd Engels; Tanja Schirmeister
Journal:  Front Mol Biosci       Date:  2022-01-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.